Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.

Samuel Pintos-Rodríguez Irene Visos-Varela Almudena Rodríguez-Fernández Maruxa Zapata-Cachafeiro María Piñeiro-Lamas María Teresa Herdeiro Rosa María García-Álvarez Adolfo Figueiras Ángel Salgado-Barreira

Published in: The international journal of neuropsychopharmacology (2024)

The results of our large-scale real-world data study suggest that antipsychotic use is not associated with a greater risk of hospitalization due to COVID-19 and progression to hospitalization among patients younger than 65 years. The effect found in the group aged 65 years or older might be associated with off-label use of antipsychotics.

Keyphrases

coronavirus disease
sars cov
electronic health record
early onset
machine learning
deep learning
respiratory syndrome coronavirus
data analysis